SuRo Capital Corp
NASDAQ:SSSS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.46
10.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
SuRo Capital Corp
SuRo Capital (Nasdaq: SSSS, formerly known as GSV Capital) is a publicly-traded fund that seeks to invest in high-growth, venture-backed private companies. The company is headquartered in New York City, New York and currently employs 9 full-time employees. The company went IPO on 2011-04-28. The firm's investment objective is to maximize its portfolio’s total return, principally by seeking capital gains on equity and equity-related investments, and to a lesser extent, income from debt investments. The firm acquires its investments through direct investments in prospective portfolio companies, secondary marketplaces for private companies, and negotiations with selling stockholders. In addition, the Company invests in private credit and in the founders equity, founders warrants, forward purchase agreements, and private investment in public equity (PIPE) transactions of special purpose acquisition companies (SPACs). The company may also invest on an opportunistic basis in select publicly traded equity securities or certain non-United States companies and make investments in private equity funds and hedge funds. The firm's investor adviser is GSV Asset Management, LLC.
SuRo Capital (Nasdaq: SSSS, formerly known as GSV Capital) is a publicly-traded fund that seeks to invest in high-growth, venture-backed private companies. The company is headquartered in New York City, New York and currently employs 9 full-time employees. The company went IPO on 2011-04-28. The firm's investment objective is to maximize its portfolio’s total return, principally by seeking capital gains on equity and equity-related investments, and to a lesser extent, income from debt investments. The firm acquires its investments through direct investments in prospective portfolio companies, secondary marketplaces for private companies, and negotiations with selling stockholders. In addition, the Company invests in private credit and in the founders equity, founders warrants, forward purchase agreements, and private investment in public equity (PIPE) transactions of special purpose acquisition companies (SPACs). The company may also invest on an opportunistic basis in select publicly traded equity securities or certain non-United States companies and make investments in private equity funds and hedge funds. The firm's investor adviser is GSV Asset Management, LLC.
Strong AI Focus: SuRo Capital highlighted its early, conviction-driven investments in AI infrastructure—CoreWeave, OpenAI, and VAST Data—which have delivered transformative returns and positioned the portfolio for generational growth.
Portfolio Growth: Net asset value per share increased to $9.23 from $9.18 in the prior quarter, primarily due to appreciation in key holdings and realized gains.
Key Monetizations: The company sold portions of its CoreWeave position, generating over $14 million in proceeds to date, while still retaining a significant stake.
Dividend & Buybacks: A $0.25 per share dividend was declared, with more distributions likely in Q4 or early 2026; share and note repurchase programs were extended.
OpenAI Valuation: Media reports suggest a potential $1 trillion IPO for OpenAI, which could make up about a third of SuRo’s net assets on a pro forma basis.
New Investments: SuRo invested $5 million in HL Digital Assets (HYPE/Hyperliquid) and made a follow-on investment in Liquid Death.
Portfolio Concentration: The top five positions account for 52% and the top ten for 75% of the portfolio's fair value, with AI infrastructure as the largest segment.
